Loading stock data…
RDY
$13.72+0.08 (+0.59%)
Market ClosedLast close May 1
Dr.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Dr. Reddy's Laboratories Limited in the Healthcare sector is trading at $13.72. The stock is currently 15% below its 52-week high of $16.17, remaining 1.9% below its 200-day moving average. Technical signals show neutral RSI of 58 and bullish MACD crossover, explaining why RDY maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 58) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$13.72
Potential Upside
19.7%
Whystock Fair Value$16.42
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus5 analysts
Hold
Mean target$14.15+3.1%
Range$11.01 – $16.40
Fundamentals
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$10.72B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
17.59
Beta
Defensive asset. Lower volatility than the S&P 500.
0.30
Div Yield
Strong income play. Yield provides a meaningful total return floor.
72.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
15.25%
Volume
Today's trading volume
2.00M
Recent News
Asian Equities Traded in the US as American Depositary Receipts Rise Slightly Higher in Friday Trading; End Week on Flat Note
Asian equities traded in the US as American depositary receipts were tracking slightly higher Friday
Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
Asian equities traded in the US as American depositary receipts were tracking moderately higher Thur
AMPH vs. RDY: Which Stock Should Value Investors Buy Now?
AMPH vs. RDY: Which Stock Is the Better Value Option?
Asian Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading
Asian equities traded in the US as American depositary receipts were little changed Wednesday mornin
AMRX Valuation: What 1.69x Sales Means for Investors
Amneal trades at 1.69x sales, below sector benchmarks, as investors weigh raised 2026 profit guidance against Specialty pressure and launch execution.